Frabex Capsule

About Frabex 250 mg Capsule

Frabex is a 250 mg capsule made by Square Pharmaceuticals PLC. It contains tranexamic acid, a medicine that helps reduce bleeding by acting on the body's clot-dissolving process. Doctors use it in medical and surgical situations where bleeding needs to be controlled.

There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.

What is Frabex 250 mg Capsule?

Frabex 250 mg capsules are produced by Square Pharmaceuticals PLC and contain tranexamic acid, a medicine classed as an anti-fibrinolytic drug. It works by blocking the body's natural clot-breaking process, which helps blood clots stay in place and can reduce bleeding. Doctors use it in a range of medical and surgical situations where bleeding is a concern, including certain bleeding disorders and during operations. It is available only on prescription, and the decision to use it, along with the dose and course, rests with your doctor. Tell your doctor about any other medicines you take, because some can interact with it.

Uses of Frabex

Frabex is used to help prevent and treat bleeding in several situations. Doctors may prescribe it for bleeding linked to conditions such as haemophilia, leukaemia, cirrhosis and low platelet counts, for bleeding in the digestive tract or lungs, and around certain treatments and transfusions. It is also used in surgery, including chest, heart and lung operations, to help limit bleeding. Not every bleeding problem is treated with it, so your doctor will decide whether it suits your situation.

How to use Frabex

Frabex 250 mg capsules are taken by mouth. The doctor decides the dose, how often you take it and how long your course lasts, based on your condition and needs. Swallow the capsule as your doctor or pharmacist advises. Do not change the amount or stop early without speaking to your doctor, even if you feel better. If you forget a dose, ask your doctor or pharmacist what to do. Keep all appointments so your doctor can check how the treatment is going.

Side effects of Frabex

Frabex is generally well tolerated, but some people may notice side effects. These can include tiredness, eye irritation, a blocked nose, itching, skin redness or a rash. After taking it by mouth, nausea, diarrhoea or stomach burning may occur, and a drop in blood pressure on standing has been reported rarely. If you have a reaction suggesting allergy, stop and get medical advice. Tell your doctor about any side effect that worries you, and seek help quickly if it is severe.

Safety and precautions

Do not take Frabex if you are allergic to tranexamic acid or have a history of blood clots in arteries or veins, certain internal bleeding, or serious kidney failure. It is not to be used during known or suspected pregnancy. It passes into breast milk in small amounts, so discuss breastfeeding with your doctor. Use caution if you have milder kidney problems. Medicines containing oestrogen, such as oral contraceptives, and clot-dissolving drugs can interact with it. Tell your doctor about all medicines you take, and ask your doctor or pharmacist before starting it.

Frequently asked questions

What is Frabex used for, and what kind of medicine is it?

Frabex contains tranexamic acid, an anti-fibrinolytic medicine. It is used to help prevent and treat bleeding in conditions such as certain bleeding disorders, bleeding in the digestive tract or lungs, and during some operations. Your doctor will decide if it is suitable for your situation.

How should I take Frabex capsules?

Take Frabex by mouth as your doctor or pharmacist instructs. The doctor decides the dose, how often you take it and how long the course lasts. Do not change the amount or stop early on your own. Ask your doctor or pharmacist what to do if you miss a dose.

What side effects should I watch for, and when should I call the doctor?

Watch for tiredness, eye irritation, a blocked nose, itching, skin redness or rash, and stomach upset such as nausea or diarrhoea. Stop and get medical advice if you think you are having an allergic reaction. Call your doctor about any side effect that is severe, unusual or does not go away.

Who should ask a doctor before using Frabex?

Ask your doctor first if you have had blood clots, have kidney problems, are pregnant or planning pregnancy, or are breastfeeding. Also tell your doctor about all other medicines you take, including oral contraceptives and clot-dissolving drugs, so they can check for interactions.

Indications

In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.

In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.

In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.

In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.

In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.

In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.

Pharmacology

This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.

The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.

Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.

Dosage & Administration

Adults-
  • The usual dose: 500-1000 mg 3 times daily.
  • For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
  • For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
  • For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
  • For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.

Interaction

Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.

Contraindications

Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.

Side Effects

  • Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
  • After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
  • There are rare cases of postural hypotension.
  • In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.

Pregnancy & Lactation

Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.

Precautions & Warnings

  • Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
  • The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
  • In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
  • Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
  • The administration of product requires particular care in cardiopathic and hepatopathic subjects.

Storage Conditions

Store in a dry place at 15-30°C, away from light and keep out of children's reach.

Alternative brands of Tranexamic Acid

Other brands with the same generic name, cheapest first.

Anaxyl Capsule

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

Anaxyl Tablet

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

See all 35 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.